Depleted mucosal antioxidant defences in inflammatory bowel disease

Publisher： Elsevier

ISSN： 0891-5849

Source： Free Radical Biology and Medicine, Vol.19, Iss.6, 1995-12, pp. : 911-918

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alicaforsen therapy in inflammatory bowel disease

By Barish Charles F

Expert Opinion on Biological Therapy, Vol. 5, Iss. 10, 2005-10 ,pp. : 1387-1391

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-10-based therapy for inflammatory bowel disease

By Braat Henri Peppelenbosch Maikel P Hommes Daan W

Expert Opinion on Biological Therapy, Vol. 3, Iss. 5, 2003-08 ,pp. : 725-731

Informa Healthcare

Access to resources Recommend Favorite

Adrenomedullin as a Potential Therapeutic Agent for Inflammatory Bowel Disease

Current Protein and Peptide Science, Vol. 14, Iss. 4, 2013-06 ,pp. : 246-255

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting TNF-α for the treatment of inflammatory bowel disease

By Billiet Thomas Rutgeerts Paul Ferrante Marc Van Assche Gert Vermeire Séverine

Expert Opinion on Biological Therapy, Vol. 14, Iss. 1, 2014-01 ,pp. : 75-101

Informa Healthcare

Access to resources Recommend Favorite

Feasibility of FDG PET in Inflammatory Bowel Disease

Current Molecular Imaging, Vol. 3, Iss. 3, 2014-01 ,pp. : 195-205

Bentham Science Publishers

Access to resources Recommend Favorite